Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation

A.M. McKillop; N.A. Duffy; Brian Green; S. Patterson; F.P.M. O'Harte; Patrick M Bell; P.R. Flatt; John Lindsay

doi:10.1530/EJE-09-0547

Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation

A.M. McKillop, N.A. Duffy, Brian Green, S. Patterson, F.P.M. O'Harte, Patrick M Bell, P.R. Flatt, John Lindsay

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Background: Nateglinide restores early-phase insulin secretion to feeding and reduces postprandial hyperglycaemia in type 2 diabetes. This study evaluated the effects of nateglinide on dipeptidyl peptidase-IV (DPP-IV) activity and glucose-dependent insulinotropic polypeptide (GIP) degradation

Original language	English
Pages (from-to)	877-885
Number of pages	9
Journal	European Journal of Endocrinology
Volume	161
Issue number	6
DOIs	https://doi.org/10.1530/EJE-09-0547
Publication status	Published - 2009

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1530/EJE-09-0547

Cite this

McKillop, A. M., Duffy, N. A., Green, B., Patterson, S., O'Harte, F. P. M., Bell, P. M., Flatt, P. R., & Lindsay, J. (2009). Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation. European Journal of Endocrinology, 161(6), 877-885. https://doi.org/10.1530/EJE-09-0547

@article{68f9a9838a0544398259ce38682d4662,

title = "Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation",

abstract = "Background: Nateglinide restores early-phase insulin secretion to feeding and reduces postprandial hyperglycaemia in type 2 diabetes. This study evaluated the effects of nateglinide on dipeptidyl peptidase-IV (DPP-IV) activity and glucose-dependent insulinotropic polypeptide (GIP) degradation",

author = "A.M. McKillop and N.A. Duffy and Brian Green and S. Patterson and F.P.M. O'Harte and Bell, {Patrick M} and P.R. Flatt and John Lindsay",

year = "2009",

doi = "10.1530/EJE-09-0547",

language = "English",

volume = "161",

pages = "877--885",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "BioScientifica Ltd.",

number = "6",

}

McKillop, AM, Duffy, NA, Green, B, Patterson, S, O'Harte, FPM, Bell, PM, Flatt, PR & Lindsay, J 2009, 'Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation', European Journal of Endocrinology, vol. 161, no. 6, pp. 877-885. https://doi.org/10.1530/EJE-09-0547

TY - JOUR

T1 - Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation

AU - McKillop, A.M.

AU - Duffy, N.A.

AU - Green, Brian

AU - Patterson, S.

AU - O'Harte, F.P.M.

AU - Bell, Patrick M

AU - Flatt, P.R.

AU - Lindsay, John

PY - 2009

Y1 - 2009

N2 - Background: Nateglinide restores early-phase insulin secretion to feeding and reduces postprandial hyperglycaemia in type 2 diabetes. This study evaluated the effects of nateglinide on dipeptidyl peptidase-IV (DPP-IV) activity and glucose-dependent insulinotropic polypeptide (GIP) degradation

AB - Background: Nateglinide restores early-phase insulin secretion to feeding and reduces postprandial hyperglycaemia in type 2 diabetes. This study evaluated the effects of nateglinide on dipeptidyl peptidase-IV (DPP-IV) activity and glucose-dependent insulinotropic polypeptide (GIP) degradation

U2 - 10.1530/EJE-09-0547

DO - 10.1530/EJE-09-0547

M3 - Article

VL - 161

SP - 877

EP - 885

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 6

ER -

Insulinotropic actions of nateglinide in type 2 diabetic patients and effects on dipeptidyl peptidase-IV activity and glucose-dependent insulinotropic polypeptide degradation

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this